Advisornet Financial’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,000
| Closed | -$6.2K | – | 2036 |
|
|
2023
Q4 | $6.2K | Hold |
5,000
| – | – | ﹤0.01% | 1445 |
|
|
2023
Q3 | $5.7K | Hold |
5,000
| – | – | ﹤0.01% | 1392 |
|
|
2023
Q2 | $4.58K | Hold |
5,000
| – | – | ﹤0.01% | 1527 |
|
|
2023
Q1 | $2.8K | Hold |
5,000
| – | – | ﹤0.01% | 1616 |
|
|
2022
Q4 | $2.89K | Hold |
5,000
| – | – | ﹤0.01% | 1587 |
|
|
2022
Q3 | $2K | Hold |
5,000
| – | – | ﹤0.01% | 1626 |
|
|
2022
Q2 | $2K | Hold |
5,000
| – | – | ﹤0.01% | 1650 |
|
|
2022
Q1 | $4K | Buy |
+5,000
| New | +$4K | ﹤0.01% | 1632 |
|
|
2019
Q2 | – | Sell |
-975
| Closed | -$8K | – | 1671 |
|
|
2019
Q1 | $8K | Hold |
975
| – | – | ﹤0.01% | 1221 |
|
|
2018
Q4 | $5K | Hold |
975
| – | – | ﹤0.01% | 1218 |
|
|
2018
Q3 | $9K | Hold |
975
| – | – | ﹤0.01% | 1137 |
|
|
2018
Q2 | $10K | Hold |
975
| – | – | ﹤0.01% | 1132 |
|
|
2018
Q1 | $9K | Buy |
+975
| New | +$9K | ﹤0.01% | 1111 |
|